Up to June 30, 2013, the Telethon Foundation has invested over € 394 million to fund 2470 research projects, which have yielded 9350 articles in international scientific journals.
From Telethon-funded gene therapy comes a new weapon in the battle against cancer
The innovative technique developed in the laboratories of the Telethon San Raffaele Institute for Gene Therapy for the treatment of two extremely serious genetic diseases can also be effective in treating tumours.
TIGEM: a centre of excellence for the south
The new premises of the Telethon Institute for Genetics and Medicine (Tigem) is set to open in the former "Olivetti area" in Pozzuoli.
€ 30,500,000 for Telethon research thanks to italian generosity
A solidarity marathon conducted thanks to Italian generosity: a special edition of a popular quiz show brought the curtain down on the fundraising campaign broadcast on the RAI TV and radio networks that brought in donations totalling € 30,500,000;
Research into a rare kidney disease reveals a mechanism responsible for hypertension
Research into a rare kidney disease has shed important light on a possible way to tackle high blood pressure, a risk factor for the circulatory system that in Italy alone affects a third of the adult population.
Polycystic kidney: a problem of tubule expansion lies at the base of polycystic kidney disease
New light has been shed on the molecular mechanisms that lie at the base of one of the most common genetic diseases, autosomal dominant polycystic kidney, which in Italy alone affects 60 thousand people.
Collaboration agreement between Telethon Foundation and Rare Partners
Telethon has renewed the agreement with Rare Partners for the development of diagnostic tools and therapeutic approaches based on the results of research projects funded by the Telethon Foundation.
Possible culprits in congenital heart defects identified
Researchers at Washington University School of Medicine in St. Louis and the University of Padua-Dulbecco Telethon Institute in Italy have shown that mitochondria remarkably also orchestrate events that determine a cell's future, at least in the embryonic mouse heart
New "muscle-saver" molecular strategy discovered
A new molecular strategy is described for enhancement of muscle growth and for consequent containment of the adverse effects of degenerative diseases such as muscular dystrophy and atrophy